What is the Return on Assets (ROA) of Cryosite this year?
The Return on Assets (ROA) of Cryosite is 0.09 undefined this year.
Cryosite ROA 2024
Cryosite ROA
0.09
Ticker
CTE.AX
ISIN
AU000000CTE1
WKN
621943
In 2024, Cryosite's return on assets (ROA) was 0.09, a 47.15% increase from the 0.06 ROA in the previous year.
Cryosite Aktienanalyse
What does Cryosite do?
Cryosite Ltd was founded in Australia in 1999 and has since become a leading provider of services in the field of biological sample storage. The company specializes in the storage of blood, bone marrow, tissue, and other biological samples. Based in Sydney, Cryosite Ltd operates branches throughout Australia and is increasingly expanding into international business. Cryosite Ltd's business model is based on providing secure and reliable storage solutions for biological samples. This includes the collection, processing, and storage of biological samples, as well as their transportation and traceability. Cryosite Ltd offers its customers a comprehensive range of services to facilitate the storage and shipment of biological samples. This includes the development of customized archiving solutions tailored to individual needs. The company's various divisions include archiving solutions, clinical trials, stem cell therapy, biobanking, and blood banks. Cryosite Ltd's archiving solutions involve the setup, maintenance, and monitoring of biological samples in engraved tubes and boxes. The company offers a variety of cryopreservation systems to ensure that samples are stored under optimal conditions and can be retrieved within a specified timeframe. Additionally, the company also provides digital archiving solutions that enable efficient management and retrieval of stored data. Cryosite Ltd is also involved in clinical trials by assisting companies in conducting clinical studies. The company provides the necessary logistics and sample management to ensure that samples are properly processed, stored, and returned. It also provides comprehensive documentation to ensure the highest compliance standards. In the field of stem cell therapy, Cryosite Ltd offers a wide range of services that enable companies and researchers to store and process stem cells under optimal conditions. The company specializes in providing a wide range of application-oriented solutions and is a leader in the industry in supporting customers in the use of these technologies to enhance diagnostic and therapeutic discoveries. In the field of biobanking, Cryosite Ltd offers a comprehensive range of services to research institutes and organizations. Biobanking services include the setup, storage, monitoring, and tracking of biological samples for future research purposes. The company also offers services for the biobanking of clinical samples for disease diagnosis and evaluation. The company also operates blood banks that focus on blood donation and storage of blood products for efficient availability to patients. It offers a wide range of blood bank products and services to ensure effective blood supply for patients. Cryosite Ltd is committed to providing its customers with the highest standards in the storage and handling of blood products. In summary, Cryosite Ltd is a leading provider of storage and processing services for biological samples. The company has a long history of providing solutions for a wide range of applications in medical research and the medical industry. It strives to meet the highest standards and ensure that all samples are processed and stored efficiently and safely. Cryosite Ltd stays up to date with the latest technology and advanced processes to handle samples with maximum efficiency and quality. Cryosite ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding Cryosite's Return on Assets (ROA)
Cryosite's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing Cryosite's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider Cryosite's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in Cryosite’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about Cryosite stock
What was the ROA of Cryosite compared to the previous year?
The ROA of Cryosite has increased by 47.15% compared to the previous year.
What consequences do high ROA have for investors of Cryosite?
A high ROA is advantageous for investors of Cryosite, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in Cryosite?
A low ROA can be unfavorable for investors of Cryosite as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of Cryosite affect the company?
An increase in ROA of Cryosite can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of Cryosite impact the company?
A reduction in the ROA of Cryosite can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of Cryosite?
Some factors that can influence the ROA of Cryosite include revenue, operating costs, asset structure, and industry average.
Why is the ROA of Cryosite important for investors?
The ROA of Cryosite is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can Cryosite take to improve ROA?
To improve ROA, Cryosite can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does Cryosite pay?
Over the past 12 months, Cryosite paid a dividend of 0.07 AUD . This corresponds to a dividend yield of about 8.75 %. For the coming 12 months, Cryosite is expected to pay a dividend of 0.07 AUD.
What is the dividend yield of Cryosite?
The current dividend yield of Cryosite is 8.75 %.
When does Cryosite pay dividends?
Cryosite pays a quarterly dividend. This is distributed in the months of October, October, March, October.
How secure is the dividend of Cryosite?
Cryosite paid dividends every year for the past 3 years.
What is the dividend of Cryosite?
For the upcoming 12 months, dividends amounting to 0.07 AUD are expected. This corresponds to a dividend yield of 8.75 %.
In which sector is Cryosite located?
Cryosite is assigned to the 'Health' sector.
Wann musste ich die Aktien von Cryosite kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Cryosite from 10/10/2024 amounting to 0.02 AUD, you needed to have the stock in your portfolio before the ex-date on 9/6/2024.
When did Cryosite pay the last dividend?
The last dividend was paid out on 10/10/2024.
What was the dividend of Cryosite in the year 2023?
In the year 2023, Cryosite distributed 0.015 AUD as dividends.
In which currency does Cryosite pay out the dividend?
The dividends of Cryosite are distributed in AUD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Cryosite
Our stock analysis for Cryosite Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cryosite Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
